Agenus Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Author's Avatar
Aug 15, 2018
Article's Main Image

- Cash milestones earned from Merck & Incyte

- Three INDs filed and 3 more to be filed during 2018

- CTLA-4 & PD-1 trials treated more than 115 patients; clinical benefit confirmed

PR Newswire